- Home
- CGEN vs GGT Comparison
CGEN vs GGT Comparison
Compare CGEN & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- GGT
- Stock Information
- Founded
- CGEN 1993
- GGT 1994
- Country
- CGEN Israel
- GGT United States
- Employees
- CGEN N/A
- GGT N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- GGT Trusts Except Educational Religious and Charitable
- Sector
- CGEN Health Care
- GGT Finance
- Exchange
- CGEN Nasdaq
- GGT Nasdaq
- Market Cap
- CGEN 167.4M
- GGT 134.4M
- IPO Year
- CGEN 2000
- GGT N/A
- Fundamental
- Price
- CGEN $1.64
- GGT $3.93
- Analyst Decision
- CGEN
- GGT
- Analyst Count
- CGEN 0
- GGT 0
- Target Price
- CGEN N/A
- GGT N/A
- AVG Volume (30 Days)
- CGEN 264.8K
- GGT 59.7K
- Earning Date
- CGEN 08-05-2025
- GGT 01-01-0001
- Dividend Yield
- CGEN N/A
- GGT 15.56%
- EPS Growth
- CGEN N/A
- GGT N/A
- EPS
- CGEN N/A
- GGT 0.83
- Revenue
- CGEN $27,589,000.00
- GGT N/A
- Revenue This Year
- CGEN N/A
- GGT N/A
- Revenue Next Year
- CGEN $173.80
- GGT N/A
- P/E Ratio
- CGEN N/A
- GGT $6.90
- Revenue Growth
- CGEN N/A
- GGT N/A
- 52 Week Low
- CGEN $1.13
- GGT $4.32
- 52 Week High
- CGEN $2.66
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- CGEN 54.29
- GGT 31.67
- Support Level
- CGEN $1.65
- GGT $3.75
- Resistance Level
- CGEN $1.83
- GGT $4.06
- Average True Range (ATR)
- CGEN 0.10
- GGT 0.07
- MACD
- CGEN -0.01
- GGT -0.00
- Stochastic Oscillator
- CGEN 47.50
- GGT 47.37
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.